User:XyZAn/sandbox/allergan
Allergan, inc acquisition and Actavis, plc name change
[edit]In November 2014 Actavis, plc announced its intention to acquire Allergan, inc, the manufacturer of Botox[1] Completion of the deal would increase its market capitalization to $147 billion.[2][3] On March 17, 2015, Actavis, plc completed the acquisition of Allergan, inc in a cash and equity transaction valued at approximately $70.5 billion. The combination created a $23 billion diversified global pharmaceutical company with commercial reach across 100 countries. In June 2015, Actavis, plc officially changed its name to Allergan, plc.[4]
|
Division sold in 2015 to Teva Pharmaceuticals |
- ^ "Actavis to buy Botox-maker Allergan $66bn". BBC News. 17 November 2014. Retrieved 27 November 2015.
- ^ Chen, Caroline (17 November 2014). "Actavis Surges to Top Drugmaker Ranks With Acquisitions". Bloomberg. Retrieved 27 November 2015.
- ^ Willhite, James (17 November 2014). "The Morning Ledger: Actavis Could Again Evade Treasury's Grasp for Post-Inversion Tax Break". The Wall Street Journal.
{{cite news}}
: Unknown parameter|subscription=
ignored (|url-access=
suggested) (help) - ^ "Actavis plc is now Allergan plc". Allergan. 15 June 2015. Retrieved 16 June 2015.